Avrobio Inc (AVRO)
1.255
0.00 (0.00%)
USD |
NASDAQ |
May 08, 10:23
Avrobio Price to Book Value: 0.5946 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 0.597 |
| May 06, 2024 | 0.5875 |
| May 03, 2024 | 0.578 |
| May 02, 2024 | 0.5828 |
| May 01, 2024 | 0.578 |
| April 30, 2024 | 0.5638 |
| April 29, 2024 | 0.5638 |
| April 26, 2024 | 0.5732 |
| April 25, 2024 | 0.5613 |
| April 24, 2024 | 0.5637 |
| April 23, 2024 | 0.5732 |
| April 22, 2024 | 0.5684 |
| April 19, 2024 | 0.5684 |
| April 18, 2024 | 0.5874 |
| April 17, 2024 | 0.5779 |
| April 16, 2024 | 0.5969 |
| April 15, 2024 | 0.5969 |
| April 12, 2024 | 0.6016 |
| April 11, 2024 | 0.6016 |
| April 10, 2024 | 0.5921 |
| April 09, 2024 | 0.5969 |
| April 08, 2024 | 0.5969 |
| April 05, 2024 | 0.6016 |
| April 04, 2024 | 0.6205 |
| April 03, 2024 | 0.6158 |
| Date | Value |
|---|---|
| April 02, 2024 | 0.6063 |
| April 01, 2024 | 0.6063 |
| March 28, 2024 | 0.6063 |
| March 27, 2024 | 0.5969 |
| March 26, 2024 | 0.5969 |
| March 25, 2024 | 0.5779 |
| March 22, 2024 | 0.6063 |
| March 21, 2024 | 0.5921 |
| March 20, 2024 | 0.6063 |
| March 19, 2024 | 0.5969 |
| March 18, 2024 | 0.6111 |
| March 15, 2024 | 0.6158 |
| March 14, 2024 | 0.6014 |
| March 13, 2024 | 0.6108 |
| March 12, 2024 | 0.6061 |
| March 11, 2024 | 0.6156 |
| March 08, 2024 | 0.6203 |
| March 07, 2024 | 0.6203 |
| March 06, 2024 | 0.6317 |
| March 05, 2024 | 0.6128 |
| March 04, 2024 | 0.6175 |
| March 01, 2024 | 0.6269 |
| February 29, 2024 | 0.6175 |
| February 28, 2024 | 0.6222 |
| February 27, 2024 | 0.6128 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2291
Minimum
May 18 2022
7.866
Maximum
Jul 25 2019
1.666
Average
1.178
Median
Price to Book Value Benchmarks
| Axonics Inc | 5.476 |
| Catalent Inc | 2.768 |
| AIM ImmunoTech Inc | 2.308 |
| Protalix BioTherapeutics Inc | 2.448 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 4.648 |
| Price | 1.255 |
| Earnings Yield | 21.51% |
| Market Cap | 56.33M |